

Pilot selective screening and its advantages for early diagnostic of Duchenne/Becker muscular dystrophy in children of the second year of life
https://doi.org/10.25557/2073-7998.2025.05.23-26
Abstract
Introduction. Early diagnosis and prevention play a key role in providing primary care to patients with hereditary diseases. However, not all diseases for various reasons, including severe neuromuscular pathology – Duchenne/Becker muscular dystrophy (DMD/BMD), can be detected today in the neonatal period in the Russian Federation.
Aim: to test the system of two-stage screening of DMD/BMD in children of the 2nd year of life in St. Petersburg for further implementation in the healthcare system of the city of St. Petersburg.
Methods. Venous blood samples from 1878 boys were studied step by step using the following methods: IFCC, MLPA, СMA.
Results. In 2024, 4 patients with pathogenic variants in the DMD gene were identified – 1 patient as a part of the screening system and 3 patients due to the orphan alertness of doctors and the inclusion of these patients in the pilot program.
Conclusions. The preliminary results of the pilot screening of the examined patients confirm the prospect of the proposed two-stage screening program for the early diagnosis of Duchenne/Becker muscular dystrophy.
About the Authors
A. A. AtsapkinaRussian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
A. V. Kiselev
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
M. A. Maretina
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
Yu. P. Maretina
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
Zh. N. Tumasova
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
O. V. Malysheva
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
N. M. Dvoynova
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
I. B. Sosnina
Russian Federation
36, building 2, Aleksa Dundić st., St. Petersburg, 192289, Russian Federation
E. V. Snegova
Russian Federation
36, building 2, Aleksa Dundić st., St. Petersburg, 192289, Russian Federation
O. A. Klimenkova
Russian Federation
36, building 2, Aleksa Dundić st., St. Petersburg, 192289, Russian Federation
Yu. A. Nasikhova
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
O. S. Glotov
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
O. N. Bespalova
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
I. Yu. Kogan
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
A. S. Glotov
Russian Federation
3, Mendeleevskaya line, St. Petersburg, 199034, Russian Federation
References
1. Mah J.K., Korngut L., Dykeman J., et al.. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 2014;24(6):482-91. doi: 10.1016/j.nmd.2014.03.008.
2. Illarioshkin S. N., Ivanova-Smolenskaya I. A., Markova E. D. DNKdiagnostika i mediko-geneticheskoye konsul’tirovaniye v nevrologii [DNA diagnostics and genetic counseling in neurology]. M.: Meditsinskoye informatsionnoye agentstvo [Moscow: Medical Information Agency]. 2002;135-144. (In Russ.)
3. Blake D.J., Weir A., Newey S.E., Davies K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiological Reviews. 2002;82:291-329.
4. Bushby K., Finkel R., Birnkrant D.J., et al. DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6.
5. Aartsma-Rus A., Ginjaar I..B, Bushby K. The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet. 2016;53(3):145-51. doi: 10.1136/jmedgenet-2015-103387.
6. Glotov A.S., Kiselev A.V., Maretina M.A., et al. Itogi pilotnogo proyekta po neonatal’nomu skriningu spinal’noy myshechnoy atrofii v Sankt-Peterburge: organizatsionnyye, diagnosticheskiye i klinicheskiye aspekty [Aftermath of the pilot project on neonatal screening for spinal muscular atrophy in the City of Saint Petersburg. Organizational, diagnostic and clinical aspect]. Pediatriya im. G.N. Speranskogo [Pediatria n.a. G.N. Speransky]. 2023; 102 (3): 79-94. (In Russ.) DOI: 10.24110/0031-403X-2023-102-3-79-94
Review
For citations:
Atsapkina A.A., Kiselev A.V., Maretina M.A., Maretina Yu.P., Tumasova Zh.N., Malysheva O.V., Dvoynova N.M., Sosnina I.B., Snegova E.V., Klimenkova O.A., Nasikhova Yu.A., Glotov O.S., Bespalova O.N., Kogan I.Yu., Glotov A.S. Pilot selective screening and its advantages for early diagnostic of Duchenne/Becker muscular dystrophy in children of the second year of life. Medical Genetics. 2025;24(5):23-26. (In Russ.) https://doi.org/10.25557/2073-7998.2025.05.23-26